Hasebe M, Su CY, Keidai Y, Minamino H, et al. Cardiovascular risk reduction with glucagon-like peptide-1 receptor agonists is proportional to HbA1c lowering in type 2 diabetes: An updated meta-regression analysis incorporating FLOW and SOUL trials. Diabetes Obes Metab 2025 Sep 9. doi: 10.1111/dom.70121.
PMID: 40926380